Chlormerodrin is a diuretic that was once used to treat patients with heart failure but is no longer used in the United States.
List of articles in "Drug" category - Page 72
Intravenous sodium bicarbonate
Intravenous sodium bicarbonate (trade names including Baros) is a solution for intravenous administration that increases plasma bicarbonate buffers excess hydrogen ion concentration raises blood pH and reverses the clinical manifestations […]
8-Carboxamidocyclazocine
8-Carboxamidocyclazocine (8-CAC) is an opioid analgesic drug related to cyclazocine invented by medicinal chemist Mark P. Wentland and co-workers in Cogswell Laboratory at Rensselaer Polytechnic Institute. Similarly to cyclazocine 8-CAC […]
L-368899
L-368899 is a drug used in scientific research which acts as a selective antagonist of the oxytocin receptor with good selectivity over the related vasopressin receptors. Unlike related drugs such […]
GSK-789472
GSK-789472 is a drug which acts as both a potent and selective partial agonist at the dopamine receptor D2 as well as an antagonist at the related D3 subtype but […]
L-741626
L-741626 is a drug which acts as a potent and selective antagonist for the dopamine receptor D2. It has good selectivity over the related D3 and D4 subtypes and other […]
Fentanyl/fluanisone
Fentanyl/fluanisone (trade name Hypnorm) is a veterinary combination drug consisting of fentanyl (a potent synthetic narcotic analgesic with a rapid onset and short duration of action) and fluanisone (a typical […]
Methylhomatropine
Homatropine methylbromide or Methylhomatropine bromide is a quaternary ammonium salt of methylhomatropine. It is a peripherally acting anticholinergic medication that inhibits muscarinic acetylcholine receptors and thus the parasympathetic nervous system.
Aliskiren/amlodipine/hydrochlorothiazide
The drug combination aliskiren/amlodipine/hydrochlorothiazide (INNs trade name Amturnide) is an antihypertensive approved by the U.S. Food and Drug Administration (FDA) on December 21 2010.
Denufosol
Denufosol (INN) is an inhaled drug for the treatment of cystic fibrosis being developed by Inspire Pharmaceuticals and sponsored by the Cystic Fibrosis Foundation. It was tested in two Phase […]